Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $10.8 million, versus $0 reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
